Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |